Oxidative stress induced by MPTP and MPP+: selective vulnerability of cultured mouse astrocytes1Published on the World Wide Web on 18 June 1999.1
- 19 July 1999
- journal article
- Published by Elsevier in Brain Research
- Vol. 836 (1-2) , 237-244
- https://doi.org/10.1016/s0006-8993(99)01661-3
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidasePublished by Elsevier ,2004
- Differential interactive effects of gliotoxin and MPTP in the substantia nigra and the locus coeruleus in BALB/c miceBrain Research Bulletin, 1993
- Glutathione peroxidase, glial cells and Parkinson's diseaseNeuroscience, 1993
- Intracranial microdialysis of salicylic acid to detect hydroxyl radical generation through dopamine autooxidation in the caudate nucleus: Effects of MPP+Free Radical Biology & Medicine, 1992
- Rapid ATP Loss Caused by 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine in Mouse BrainJournal of Neurochemistry, 1991
- Astrocytes as a primary locus for the conversion MPTP into MPP+Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1989
- 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity in mice is enhanced by pretreatment with diethyldithiocarbamateEuropean Journal of Pharmacology, 1985
- Neurochemical and behavioral effects of systematic and intranigral administration of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the ratEuropean Journal of Pharmacology, 1984
- A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.Proceedings of the National Academy of Sciences, 1983
- Chronic parkinsonism secondary to intravenous injection of meperidine analoguesPsychiatry Research, 1979